These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20186689)

  • 1. Functional PMS2 hybrid alleles containing a pseudogene-specific missense variant trace back to a single ancient intrachromosomal recombination event.
    Ganster C; Wernstedt A; Kehrer-Sawatzki H; Messiaen L; Schmidt K; Rahner N; Heinimann K; Fonatsch C; Zschocke J; Wimmer K
    Hum Mutat; 2010 May; 31(5):552-60. PubMed ID: 20186689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
    Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
    Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMS2 gene mutational analysis: direct cDNA sequencing to circumvent pseudogene interference.
    Wimmer K; Wernstedt A
    Methods Mol Biol; 2014; 1167():289-302. PubMed ID: 24823786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive gene conversion at the PMS2 DNA mismatch repair locus.
    Hayward BE; De Vos M; Valleley EM; Charlton RS; Taylor GR; Sheridan E; Bonthron DT
    Hum Mutat; 2007 May; 28(5):424-30. PubMed ID: 17253626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
    van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT
    Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
    Etzler J; Peyrl A; Zatkova A; Schildhaus HU; Ficek A; Merkelbach-Bruse S; Kratz CP; Attarbaschi A; Hainfellner JA; Yao S; Messiaen L; Slavc I; Wimmer K
    Hum Mutat; 2008 Feb; 29(2):299-305. PubMed ID: 18030674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
    Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
    BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
    Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
    Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
    Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
    Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting rid of the PMS2 pseudogenes: mission impossible?
    Niessen RC; Kleibeuker JH; Jager PO; Sijmons RH; Hofstra RM
    Hum Mutat; 2007 Apr; 28(4):414; author reply 415. PubMed ID: 17139668
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.
    De Vos M; Hayward BE; Picton S; Sheridan E; Bonthron DT
    Am J Hum Genet; 2004 May; 74(5):954-64. PubMed ID: 15077197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-range PCR facilitates the identification of PMS2-specific mutations.
    Clendenning M; Hampel H; LaJeunesse J; Lindblom A; Lockman J; Nilbert M; Senter L; Sotamaa K; de la Chapelle A
    Hum Mutat; 2006 May; 27(5):490-5. PubMed ID: 16619239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.
    Nomura S; Fujimoto Y; Yamamoto N; Sato Y; Ashihara Y; Kita M; Yamaguchi J; Ishikawa Y; Ueno M; Arai M
    Jpn J Clin Oncol; 2015 Oct; 45(10):987-92. PubMed ID: 26232782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
    Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
    J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in a pseudogene highly homologous to PMS2.
    Chadwick RB; Meek JE; Prior TW; Peltomaki P; de La Chapelle A
    Hum Mutat; 2000 Dec; 16(6):530. PubMed ID: 11102987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene.
    Vaughn CP; Baker CL; Samowitz WS; Swensen JJ
    Genes Chromosomes Cancer; 2013 Jan; 52(1):107-12. PubMed ID: 23012243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome.
    Clendenning M; Senter L; Hampel H; Robinson KL; Sun S; Buchanan D; Walsh MD; Nilbert M; Green J; Potter J; Lindblom A; de la Chapelle A
    J Med Genet; 2008 Jun; 45(6):340-5. PubMed ID: 18178629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reclassification of a frequent African-origin variant from PMS2 to the pseudogene PMS2CL.
    Chong AS; Chong G; Foulkes WD; Saskin A
    Hum Mutat; 2020 Apr; 41(4):749-752. PubMed ID: 31916644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.